1070 related articles for article (PubMed ID: 33573850)
1. The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved.
Coperchini F; Chiovato L; Ricci G; Croce L; Magri F; Rotondi M
Cytokine Growth Factor Rev; 2021 Apr; 58():82-91. PubMed ID: 33573850
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
Coperchini F; Chiovato L; Rotondi M
Front Immunol; 2021; 12():668507. PubMed ID: 33981314
[TBL] [Abstract][Full Text] [Related]
3. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.
Coperchini F; Chiovato L; Croce L; Magri F; Rotondi M
Cytokine Growth Factor Rev; 2020 Jun; 53():25-32. PubMed ID: 32446778
[TBL] [Abstract][Full Text] [Related]
4. Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm.
Pum A; Ennemoser M; Adage T; Kungl AJ
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33445810
[TBL] [Abstract][Full Text] [Related]
5. A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes.
Cabler SS; French AR; Orvedahl A
Trends Mol Med; 2020 Dec; 26(12):1078-1085. PubMed ID: 33051104
[TBL] [Abstract][Full Text] [Related]
6. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
[TBL] [Abstract][Full Text] [Related]
7. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.
Zheng M; Karki R; Williams EP; Yang D; Fitzpatrick E; Vogel P; Jonsson CB; Kanneganti TD
Nat Immunol; 2021 Jul; 22(7):829-838. PubMed ID: 33963333
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
9. AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm.
Gangemi S; Tonacci A
Cytokine Growth Factor Rev; 2021 Apr; 58():111-113. PubMed ID: 32938545
[TBL] [Abstract][Full Text] [Related]
10. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
[TBL] [Abstract][Full Text] [Related]
11. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
Front Immunol; 2021; 12():749291. PubMed ID: 34867978
[TBL] [Abstract][Full Text] [Related]
12. Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.
Roshanravan N; Seif F; Ostadrahimi A; Pouraghaei M; Ghaffari S
Arch Med Res; 2020 Oct; 51(7):608-612. PubMed ID: 32682575
[TBL] [Abstract][Full Text] [Related]
13. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
Sasidharakurup H; Kumar G; Nair B; Diwakar S
OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
[TBL] [Abstract][Full Text] [Related]
14. Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.
Hammoudeh SM; Hammoudeh AM; Bhamidimarri PM; Al Safar H; Mahboub B; Künstner A; Busch H; Halwani R; Hamid Q; Rahmani M; Hamoudi R
Front Immunol; 2021; 12():595150. PubMed ID: 34262555
[TBL] [Abstract][Full Text] [Related]
15. Controlling Cytokine Storm Is Vital in COVID-19.
Tang L; Yin Z; Hu Y; Mei H
Front Immunol; 2020; 11():570993. PubMed ID: 33329533
[TBL] [Abstract][Full Text] [Related]
16. The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
Hsu RJ; Yu WC; Peng GR; Ye CH; Hu S; Chong PCT; Yap KY; Lee JYC; Lin WC; Yu SH
Front Immunol; 2022; 13():832394. PubMed ID: 35464491
[TBL] [Abstract][Full Text] [Related]
17. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).
Pinheiro MM; Fabbri A; Infante M
Immunotherapy; 2021 Jun; 13(9):753-765. PubMed ID: 33906375
[TBL] [Abstract][Full Text] [Related]
18. What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection?
Gudowska-Sawczuk M; Mroczko B
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409036
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2.
Cheon SY; Koo BN
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360684
[TBL] [Abstract][Full Text] [Related]
20. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications.
Shawki MA; Elsayed NS; Mantawy EM; Said RS
Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):395-409. PubMed ID: 34057871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
